CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
April 23rd 2021
In patients with resected high-risk stage 3 cutaneous melanoma, distant metastasis-free survival at 3.5 years was 65.3% in patients treated with Keytruda compared with 49.4% in those treated with placebo, which was also consistent in patients with PD-L1-positive tumors.
April 22nd 2021
Keytruda demonstrated clinical benefit for patients with recurrent and metastatic disease, according to an expert.
April 20th 2021
Active surveillance in sentinel lymph node positive melanoma could delay surgery but may result in the same risk of the cancer coming back.
April 12th 2021
Chronic immune-related adverse events from anti-PD-1 therapy occur in many patients with advanced melanoma, but shouldn’t deter them from seeking treatment that can provide long-term survival, according to an expert from Vanderbilt University Medical Center.
April 8th 2021
An expert spoke with CURE® about the FDA’s recent approval of Libtayo to treat patients with locally advanced basal cell carcinoma who previously had only one therapy option for locally advanced disease.
March 19th 2021
FDA approval of immunotherapies and BRAF/MEK inhibitors may have impacted overall survival, with a change from seven months between 2010 and 2014 to 13 months between 2015 and 2019.
March 8th 2021
As the winter months stretch on, those looking to treat Seasonal Affective Disorder (SAD) may be tempted to use indoor ultraviolet (UV) tanning devices. Not only is indoor tanning a dangerous habit, it does not successfully treat SAD.
March 1st 2021
A patient with recurrent basal cell carcinoma discusses his cancer journey, his latest challenge and how he’s now prioritized quality of life over quantity.
February 23rd 2021
Intratumoral injection—the boosting of the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses—is a promising treatment method because it’s effective AND it seems to cause fewer toxicities for the patient than combination systemic immunotherapy.
February 16th 2021
Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not to” long before she was diagnosed with metastatic melanoma.
February 9th 2021
The Food and Drug Administration has granted an accelerated approval to Libtayo for the treatment of patients with advanced basal cell carcinoma, a type of skin cancer, who were previously treated with a hedgehog pathway inhibitor (HHI) or for whom an HHI was not appropriate.
February 9th 2021
We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment; and Medical Director, Cancer Center, California Pacific Medical Center.
February 2nd 2021
We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain anonymous.
January 27th 2021
Avastin, in combination with carboplatin plus paclitaxel (types of chemotherapy), improved progression-free survival and overall survival compared with those who received chemotherapy alone for patients with untreated advanced mucosal melanoma.
January 25th 2021
Combination treatment with Opdivo and Yervoy may have better overall survival rates for patients with metastatic uveal melanoma.
January 14th 2021
In this episode of the “CURE Talks Cancer” podcast, we spoke with someone who has undergone 41 surgeries and physically debilitating treatments during his more than 15-year journey with several cases of skin cancer. We discussed his cancer journey, and why, as he starts a new treatment after his most prior therapy failed, he’s focused on quality rather than quantity of life.
January 6th 2021
A roundup of some skin cancer news and updates that occurred in 2020 that patients may have missed.
December 1st 2020
Machine learning may be used to predict disease progression in patients with advanced melanoma.
November 19th 2020
In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Ezra Cohen and two patients with advanced cutaneous squamous cell carcinoma about the disease, its treatments and their recommendations for others.
November 13th 2020
“The concept that people have sometimes is that they put doctors on a pedestal, which is fine,” Bud Green said. And they somehow think that all doctors are kind of the same, and they're all as good. And I think that they need to see that different specialties look at things from a different perspective.
November 6th 2020
Patients with resected, high-risk, stage 3 melanoma who were randomized to receive Keytruda (pembrolizumab) achieved a three-year recurrence-free survival rate of 63.7% compared to 44.1% in patients randomized to placebo.
November 3rd 2020
A two-time cancer survivor looks back at her cancer journey and offers 4 tips for a first-time patient with cancer.
November 3rd 2020
Taking cholesterol-lowering drugs may provide a mortality benefit in women with newly diagnosed colorectal cancer, breast cancer and melanoma, although more research is needed to confirm this potential association.
September 16th 2020
Recent immunotherapy approvals for patients with metastatic melanoma has widened the treatment landscape, but new research shows that patients associated with positive sociodemographic factors are more likely to receive immunotherapy.
September 15th 2020
CURE® compiled a roundup of five recent reports patients with skin cancer may have missed.
September 3rd 2020
In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Jeremy Brauer, on behalf of the Skin Cancer Foundation, about current treatment strategies and the future of the disease.
August 28th 2020
From Washington Football Team head coach Ron Rivera announcing he has cancer but plans to continue coaching this season, to ”Dancing With the Stars” judge Len Goodman revealing he had surgery to remove skin cancer from his face, here’s what’s happening in the cancer landscape this week.
August 25th 2020
“Through patients’ eyes, augmented intelligence may improve health care quality but should be implemented in a manner that preserves the integrity of the human physician-patient relationship,” the authors wrote.
August 24th 2020
Dr. Jennifer L. Atlas notes that while these results could lead to a paradigm shift, surgery and radiation aren’t being eliminated as treatment options.
August 19th 2020
“With data showing a two-fold increase in disease-free survival with the vaccine alone and in combination with checkpoint inhibitors, we hope to one day change the narrative for people with melanoma — turning this disease into a chronic condition that can be treated and managed over time,” said Dr. Mark B. Faries.